Form 4: Jupiter Neurosciences Executive Reports Stock Transaction
Insider Transaction (Form 4)
Marshall A. Hayward, Chief Scientific Officer and a Director of Jupiter Neurosciences, Inc., reported multiple transactions in common stock on June 2, 2025.
Summary
- Option exercise/conversion: acquired 389,793 Common Stock on June 2, 2025; holds 2,370,675 after (Direct).
- Option exercise/conversion: acquired 399,402 Common Stock on June 2, 2025; holds 2,770,077 after (Direct).
- Option exercise/conversion: acquired 225,000 Common Stock on March 2, 2026; holds 2,995,077 after (Direct).
- Option exercise/conversion: disposed of 389,793 Restricted Stock Units on June 2, 2025 (Direct).
- Option exercise/conversion: disposed of 399,402 Restricted Stock Award on June 2, 2025 (Direct).
- Option exercise/conversion: disposed of 225,000 Stock Option (right to buy) on March 2, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Marshall A. Hayward — Director, Officer (Chief Scientific Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2025-06-02 | Option exercise/conversion | Common Stock | 389,793 | — | — | 2,370,675 |
| 2025-06-02 | Option exercise/conversion | Common Stock | 399,402 | — | — | 2,770,077 |
| 2026-03-02 | Option exercise/conversion | Common Stock | 225,000 | — | — | 2,995,077 |
| 2025-06-02 | Option exercise/conversion | Restricted Stock Units | 389,793 | — | — | 0 |
| 2025-06-02 | Option exercise/conversion | Restricted Stock Award | 399,402 | — | — | 0 |
| 2026-03-02 | Option exercise/conversion | Stock Option (right to buy) | 225,000 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2025-06-02 | Option exercise/conversion (389,793 shares) |
| 2025-06-02 | Option exercise/conversion (399,402 shares) |
| 2026-03-02 | Option exercise/conversion (225,000 shares) |
| 2025-06-02 | Option exercise/conversion (389,793 shares) |
| 2025-06-02 | Option exercise/conversion (399,402 shares) |
| 2026-03-02 | Option exercise/conversion (225,000 shares) |
Keywords
insider transaction, Form 4, JUNS, JUPITER NEUROSCIENCES, INC., neutral, Marshall A. Hayward
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.